Dr. Jawad I. Gill

Dr. Jawad I. Gill

Dr. Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Beginning his career as a CRA at GSK in 1998 he steadily progressed to positions of greater responsibility, eventually becoming Country Head of Clinical Research (Pakistan). During this period, he worked on Phase II – IV clinical trials in Oncology, Respiratory, Dermatology, Urology, Infectious Diseases, Immunology, Psychiatry, Rheumatology and Cardiovascular (also including investigator-initiated studies, epidemiological and non-interventional studies and studies involving devices).

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.